Consistently, the importance of FOXA1 in breast and prostate cancer is underlined by our results that FOXA1 is highly expressed in various prostate and breast cancers, and that FOXA1 expression at mRNA in prostate cancer is significantly higher than that in other cancer lines (Figure 4A,B and Figure 5A). This evidence concerns the gene FOXA1 and prostate carcinoma.